NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 60.28

+6.3%

11:50 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocky9 who wrote (23)	1/26/2006 1:14:03 PM
From: tuck	Read Replies (1) of 507

Exubera approved for both types of diabetes in Europe: Message 22102460 Haven't seen anything regarding the label there. Looks as though I'll have to roll my calls to March $20s . . . I am also playing MNTA with sold puts (good money), but own my MOGN (put to me) unhedged now, the January calls having expired worthless. I think there is more up than downside now, so I'm waiting on writing another round. Just staying away from SEPR for the time being. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next